TLTFF (Theralase Technologies) Other Long Term Assets : $0.67 Mil (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Theralase Technologies Other Long Term Assets?

Theralase Technologies's other long-term assets for the quarter that ended in Sep. 2024 was $0.67 Mil.

Theralase Technologies's quarterly other long-term assets declined from Mar. 2024 ($0.67 Mil) to Jun. 2024 ($0.63 Mil) but then increased from Jun. 2024 ($0.63 Mil) to Sep. 2024 ($0.67 Mil).

Theralase Technologies's annual other long-term assets increased from Dec. 2021 ($0.06 Mil) to Dec. 2022 ($0.41 Mil) and increased from Dec. 2022 ($0.41 Mil) to Dec. 2023 ($0.69 Mil).

Theralase Technologies Other Long Term Assets Historical Data

The historical data trend for Theralase Technologies's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Other Long Term Assets Chart

Theralase Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

0.09

0.05

0.06

0.41

0.69

Theralase Technologies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Long Term Assets	Get a 7-Day Free Trial															0.60	0.69	0.67	0.63	0.67

Theralase Technologies Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Theralase Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (OTCPK:TLTFF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

TTX:Germany TTX:Germany TLT:Canada

Address

41 Hollinger Road, Toronto, ON, CAN, M4B 3G4

Website

https://www.theralase.com

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.